Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIVERA
2006-001428-38Phase 4Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of etanercept, methotrexate and methylprednisolone in rheumatoid arthritis (RA) and autoimmune arthritis (2 arms), sponsored by University Hospitals Birmingham. Started Sep 2006; status: completed.
02
Drugs
etanerceptmethotrexatemethylprednisolone
03
Conditions
rheumatoid arthritis (RA)autoimmune arthritis
Beyond the preview
Go deeper on 2006-001428-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001428-38.